Protein Carbamylation in kidney disease: Pathogenesis and clinical implications

American Journal of Kidney Diseases

Volumn 64, Issue 5, 2014, Pages 793-803

  Kalim, Sahir ^a,b   Karumanchi, S Ananth ^b,c,d   Thadhani, Ravi I ^a,b   Berg, Anders H ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

carbamoylation.; chronic kidney disease (CKD); cyanate; end stage renal disease (ESRD); INDEX WORDS: Carbamylation; inflammation; pathophysiology; posttranslational protein modification (PTM); urea; uremia

Indexed keywords

BIOLOGICAL MARKER; CYANIC ACID; HEMOGLOBIN; UREA; CARBAMIC ACID; CARBAMIC ACID DERIVATIVE;

AMINO ACID DEFICIENCY; ARTICLE; ATHEROSCLEROSIS; CARBAMOYLATION; CARDIOVASCULAR DISEASE; HEMODIALYSIS; HUMAN; INFLAMMATION; KIDNEY DISEASE; MEASUREMENT; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN PROCESSING; RISK ASSESSMENT; UREMIA; ANIMAL; CASE REPORT; KIDNEY FAILURE, CHRONIC; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CARBAMATES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTEIN PROCESSING, POST-TRANSLATIONAL; UREMIA;

EID: 84908485299     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2014.04.034     Document Type: Article

References (128)

1. S. Kalim, H. Tamez, and J. Wenger Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease Clin J Am Soc Nephrol 8 2013 1927 1934
2. A.H. Berg, C. Drechsler, and J. Wenger Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure Sci Transl Med 5 2013 175ra29
3. F. Wöhler Ueber künstliche Bildung des Harnstoffs Ann Phys 87 1828 253 256
4. J. Walker, and F.J. Hambly Transformation of ammonium cyanate into urea J Chem Soc 67 1895 746 767
5. F. Shutz Cyanate Experientia 5 1949 133 172
6. G.R. Stark, W.H. Stein, and S. Moore Reaction of the cyanate present in aqueous urea with amino acids and proteins J Biol Chem 235 1960 3177 3181
7. G.R. Stark On the reversible reaction of cyanate with sulfhydryl groups and the determination of NH2-terminal cysteine and cystine in proteins J Biol Chem 239 1964 1411 1414
8. G.R. Stark Reactions of cyanate with functional groups of proteins. 3. Reactions with amino and carboxyl groups Biochemistry 4 1965 1030 1036
9. J.F. Nyc, and H.K. Mitchell Synthesis of orotic acid from aspartic acid J Am Chem Soc 69 1947 1382 1384
10. D.G. Smyth Carbamylation of amino and tyrosine hydroxyl groups. Preparation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus J Biol Chem 242 1967 1579 1591
11. W. Jelkmann 'O', erythropoietin carbamoylation versus carbamylation [letter] Nephrol Dial Transplant 23 2008 3033 author reply, 3034
12. S. Jaisson, C. Pietrement, and P. Gillery Carbamylation-derived products: bioactive compounds and potential biomarkers in chronic kidney failure and atherosclerosis Clin Chem 57 2011 1499 1505
13. G.R. Stark Modification of proteins with cyanate Methods Enzymol 25 1972 579 584
14. F. Brotzel, Y.C. Chu, and H. Mayr Nucleophilicities of primary and secondary amines in water J Org Chem 72 2007 3679 3688
15. J.S. Claxton, P.C. Sandoval, and G. Liu Endogenous carbamylation of kidney medullary proteins PLoS One 8 2014 e82655
16. J. Carreras, A. Chabas, and D. Diederich Physiological and clinical implications of protein carbamylation S. Grisolia, R. Baguena, F. Major, The Urea Cycle 1976 John Wiley & Sons Inc New York, NY 501 548
17. P. Dirnhuber, and F. Schutz The isomeric transformation of urea into ammonium cyanate in aqueous solutions Biochem J 42 1948 628 632
18. L.M. Kraus, and A.P. Kraus Jr. Carbamoylation of amino acids and proteins in uremia Kidney Int Suppl 78 2001 S102 S107
19. L. Nilsson, P. Lundquist, B. Kagedal, and R. Larsson Plasma cyanate concentrations in chronic kidney failure Clin Chem 42 1996 482 483
20. L.M. Kraus, M.R. Jones, and A.P. Kraus Jr. Essential carbamoyl-amino acids formed in vivo in patients with end-stage kidney disease managed by continuous ambulatory peritoneal dialysis: isolation, identification, and quantitation J Lab Clin Med 131 1998 425 431
21. D. Bobb, and B.H. Hofstee Gel isoelectric focusing for following the successive carbamylations of amino groups in chymotrypsinogen A Anal Biochem 40 1971 209 217
22. S. Grisolia Enzyme regulation by substrate; rapid inactivation of glutamate dehydrogenase by carbamyl phosphate Biochem Biophys Res Commun 32 1968 56 59
23. S. Rimon, and G.E. Perlmann Carbamylation of pepsinogen and pepsin J Biol Chem 243 1968 3566 3572
24. S. Jaisson, S. Lorimier, and S. Ricard-Blum Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils Chem Biol 13 2006 149 159
25. S. Jaisson, V. Larreta-Garde, and G. Bellon Carbamylation differentially alters type I collagen sensitivity to various collagenases Matrix Biol 26 2007 190 196
26. K.C. Mun, and T.A. Golper Impaired biological activity of erythropoietin by cyanate carbamylation Blood Purif 18 2000 13 17
27. M. Leist, P. Ghezzi, and G. Grasso Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 342
28. K.D. Park, K.C. Mun, E.J. Chang, S.B. Park, and H.C. Kim Inhibition of erythropoietin activity by cyanate Scand J Urol Nephrol 38 2004 69 72
29. M. Brines, and A. Cerami Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response J Intern Med 264 2008 405 432
30. J.M. Legendre, A. Bergot, A. Turzo, P.P. Morin, and I. Humphery-Smith Modifications du point isoelectrique de la chaine-alpha de l'hemoglobine sous l'action de l'uree, du cyanate de sodium, de l'anhydride succinique ou de l'anhydride diethylene triamine pentaacetique [Hemoglobin alpha chain isoelectric point modification under the action of urea, sodium cyanate, succinic anhydride or diethylene triamine pentaacetic acid anhydride] Pathol Biol (Paris) 46 1998 605 612
31. C. Nowicki, and J.A. Santome Modification of lysine 69 reactivity in bovine growth hormone by carbamylation of its N-terminal group Int J Pept Protein Res 18 1981 52 60
32. H.T. Beswick, and J.J. Harding High-molecular-weight crystallin aggregate formation resulting from non-enzymic carbamylation of lens crystallins: relevance to cataract formation Exp Eye Res 45 1987 569 578
33. K.M. Fazili, M.M. Mir, and M.A. Qasim Changes in protein stability upon chemical modification of lysine residues of bovine serum albumin by different reagents Biochem Mol Biol Int 31 1993 807 816
34. D.C. Shaw, W.H. Stein, and S. Moore Inactivation of chymotrypsin by cyanate J Biol Chem 239 1964 671 673
35. F.G. De Furia, D.R. Miller, A. Cerami, and J.M. Manning The effects of cyanate in vitro on red blood cell metabolism and function in sickle cell anemia J Clin Invest 51 1972 566 574
36. F. Van Lente, A. McHugh, and C.E. Pippenger Carbamylation of apo-aspartate aminotransferase: a possible mechanism for enzyme inactivation in uremic patients Clin Chem 32 1986 2107 2108
37. F.M. Veronese, D. Piszkiewicz, and E.L. Smith Inactivation of bovine glutamate dehydrogenase by carbamyl phosphate and cyanate J Biol Chem 247 1972 754 759
38. M. Oimomi, H. Hatanaka, and Y. Yoshimura Carbamylation of insulin and its biological activity Nephron 46 1987 63 66
39. K.H. Weisgraber, T.L. Innerarity, and R.W. Mahley Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts J Biol Chem 253 1978 9053 9062
40. T.C. Lee, and Q.H. Gibson Allosteric properties of carbamylated hemoglobins J Biol Chem 256 1981 4570 4577
41. T.J. Dengler, G.M. Robertz-Vaupel, and H.J. Dengler Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin Eur J Clin Pharmacol 43 1992 491 499
42. S. Erill, R. Calvo, and R. Carlos Plasma protein carbamylation and decreased acidic drug protein binding in uremia Clin Pharmacol Ther 27 1980 612 618
43. E. Ha, J.H. Bang, J.N. Son, H.C. Cho, and K.C. Mun Carbamylated albumin stimulates microRNA-146, which is increased in human kidney cell carcinoma Mol Med Rep 3 2010 275 279
44. S. Jaisson, C. Delevallee-Forte, and F. Toure Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst FEBS Lett 581 2007 1509 1513
45. A.L. Maddock, and C. Westenfelder Urea induces the heat shock response in human neuroblastoma cells J Am Soc Nephrol 7 1996 275 282
46. C.M. Balion, T.F. Draisey, and R.J. Thibert Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients Kidney Int 53 1998 488 495
47. T.A. Lane, and E.R. Burka Decreased life span and membrane damage of carbamylated erythrocytes in vitro Blood 47 1976 909 917
48. R. Garnotel, N. Sabbah, S. Jaisson, and P. Gillery Enhanced activation of and increased production of matrix metalloproteinase-9 by human blood monocytes upon adhering to carbamylated collagen FEBS Lett 563 2004 13 16
49. M.L. Gross, G. Piecha, and A. Bierhaus Glycated and carbamylated albumin is more "nephrotoxic" than unmodified albumin in the amphibian kidney Am J Physiol Kidney Physiol 301 2011 F476 F485
50. C. Pietrement, L. Gorisse, S. Jaisson, and P. Gillery Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD PloS One 8 2013 e82506
51. D.S. Raj, A. Oladipo, and V.S. Lim Amino acid and protein kinetics in kidney failure: an integrated approach Semin Nephrol 26 2006 158 166
52. J.J. Carrero, P. Stenvinkel, and L. Cuppari Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Kidney Nutrition and Metabolism (ISRNM) J Ren Nutr 23 2013 77 90
53. K. Kalantar-Zadeh, N.J. Cano, and K. Budde Diets and enteral supplements for improving outcomes in chronic kidney disease Nat Rev Nephrol 7 2011 369 384
54. S.M. Schreier, H. Steinkellner, and L. Jirovetz S-Carbamoylation impairs the oxidant scavenging activity of cysteine: its possible impact on increased LDL modification in uraemia Biochimie 93 2011 772 777
55. M. Iciek, A. Bilska, E. Lorenc-Koci, L.B. Wlodek, and M.M. Sokolowska The effect of uremic toxin cyanate (OCN-) on anaerobic sulfur metabolism and prooxidative processes in the rat kidney: a protective role of lipoate Hum Exp Toxicol 30 2010 1601 1608
56. M. Sokolowska, E. Niedzielska, and M. Iciek The effect of the uremic toxin cyanate (CNO(-)) on anaerobic cysteine metabolism and oxidative processes in the rat liver: a protective effect of lipoate Toxicol Mech Methods 21 2011 473 478
57. Y.M. Go, and D.P. Jones Cysteine/cystine redox signaling in cardiovascular disease Free Radic Biol Med 50 2012 495 509
58. W. Przemyslaw, K. Piotr, and C. Grazyna Total, free, and protein-bound thiols in plasma of peritoneal dialysis and predialysis patients Int Urol Nephrol 43 2011 1201 1209
59. M. Prakash, S. Upadhya, and R. Prabhu Protein thiol oxidation and lipid peroxidation in patients with uraemia Scand J Clin Lab Invest 64 2004 599 604
60. J. Himmelfarb, E. McMonagle, and E. McMenamin Plasma protein thiol oxidation and carbonyl formation in chronic kidney failure Kidney Int 58 2000 2571 2578
61. D.S. Mohar, A. Barseghian, N. Haider, M. Domanski, and J. Narula Atherosclerosis in chronic kidney disease: lessons learned from glycation in diabetes Med Clin North Am 96 2012 57 65
62. Z. Wang, S.J. Nicholls, and E.R. Rodriguez Protein carbamylation links inflammation, smoking, uremia and atherogenesis Nat Med 13 2007 1176 1184
63. R.J. Shapiro Catabolism of low-density lipoprotein is altered in experimental chronic kidney failure Metabolism 42 1993 162 169
64. S. Horkko, M.J. Savolainen, K. Kervinen, and Y.A. Kesaniemi Carbamylation-induced alterations in low-density lipoprotein metabolism Kidney Int 41 1992 1175 1181
65. S. Horkko, K. Huttunen, K. Kervinen, and Y.A. Kesaniemi Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein Eur J Clin Invest 24 1994 105 113
66. S. Horkko, K. Huttunen, and Y.A. Kesaniemi Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment Kidney Int 47 1995 1732 1740
67. E.O. Apostolov, D. Ray, A.V. Savenka, S.V. Shah, and A.G. Basnakian Chronic uremia stimulates LDL carbamylation and atherosclerosis J Am Soc Nephrol 21 2010 1852 1857
68. S.V. Shah, E.O. Apostolov, E. Ok, and A.G. Basnakian Novel mechanisms in accelerated atherosclerosis in kidney disease J Ren Nutr 18 2008 65 69
69. E.O. Apostolov, S.V. Shah, D. Ray, and A.G. Basnakian Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL Arterioscler Thromb Vasc Biol 29 2009 1622 1630
70. E.O. Apostolov, S.V. Shah, E. Ok, and A.G. Basnakian Carbamylated low-density lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 Arterioscler Thromb Vasc Biol 27 2007 826 832
71. E. Ok, A.G. Basnakian, E.O. Apostolov, Y.M. Barri, and S.V. Shah Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease Kidney Int 68 2005 173 178
72. E.O. Apostolov, A.G. Basnakian, X. Yin, E. Ok, and S.V. Shah Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway Am J Physiol Heart Circ Physiol 292 2007 H1836 H1846
73. G. Asci, A. Basci, and S.V. Shah Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells Nephrology (Carlton) 13 2008 480 486
74. M. Holzer, M. Gauster, and T. Pfeifer Protein carbamylation renders high-density lipoprotein dysfunctional Antioxid Redox Signal 14 2011 2337 2346
75. S. Xiao, L. Wagner, J. Mahaney, and C. Baylis Uremic levels of urea inhibit L-arginine transport in cultured endothelial cells Am J Physiol Kidney Physiol 280 2001 F989 F995
76. D. El-Gamal, M. Holzer, and M. Gauster Cyanate is a novel inducer of endothelial ICAM-1 expression Antioxid Redox Signal 16 2011 129 137
77. R.A. Koeth, K. Kalantar-Zadeh, and Z. Wang Protein carbamylation predicts mortality in ESRD J Am Soc Nephrol 24 2013 853 861
78. R.M. Nalbandian, R.L. Henry, M.I. Barnhart, and F.R. Camp Jr. Sickle cell disease: clinical advances by the Murayama molecular hypothesis Mil Med 137 1972 215 220
79. J. Dean, and A.N. Schechter Sickle-cell anemia: molecular and cellular bases of therapeutic approaches (first of three parts) N Engl J Med 299 1978 752 763
80. R.M. Nalbandian, B.M. Nichols, E.J. Stehouwer, and F.R. Camp Jr. Urea, urease, cyanate, and the sickling of hemoglobin S Clin Chem 18 1972 961 964
81. P.N. Gillette, C.M. Peterson, Y.S. Lu, and A. Cerami Sodium cyanate as a potential treatment for sickle-cell disease N Engl J Med 290 1974 654 660
82. D.R. Harkness, and S. Roth Clinical evaluation of cyanate in sickle cell anemia Prog Hematol 9 1975 157 184
83. A.M. Nigen, N. Njikam, C.K. Lee, and J.M. Manning Studies on the mechanism of action of cyanate in sickle cell disease. Oxygen affinity and gelling properties of hemoglobin S carbamylated on specific chains J Biol Chem 249 1974 6611 6616
84. D.H. Nicholson, D.R. Harkness, W.E. Benson, and C.M. Peterson Cyanate-induced cataracts in patients with sickle-cell hemoglobinopathies Arch Ophthalmol 94 1976 927 930
85. V.N. Lapko, D.L. Smith, and J.B. Smith In vivo carbamylation and acetylation of water-soluble human lens alphaB-crystallin lysine 92 Protein Sci 10 2001 1130 1136
86. H.T. Beswick, and J.J. Harding Conformational changes induced in bovine lens alpha-crystallin by carbamylation. Relevance to cataract Biochem J 223 1984 221 227
87. H. Yan, J. Zhang, and J.J. Harding Identification of the preferentially targeted proteins by carbamylation during whole lens incubation by using radio-labelled potassium cyanate and mass spectrometry Int J Ophthalmol 3 2010 104 111
88. J. Zhang, H. Yan, and J.J. Harding Identification of the primary targets of carbamylation in bovine lens proteins by mass spectrometry Curr Eye Res 33 2008 963 976
89. B.K. Derham, and J.J. Harding Alpha-crystallin as a molecular chaperone Prog Retin Eye Res 18 1999 463 509
90. X. Liu, and S. Li Carbamylation of human lens gamma-crystallins: relevance to cataract formation Yan Ke Xue Bao 9 1993 136 142 157
91. J.J. Harding, and K.C. Rixon Carbamylation of lens proteins: a possible factor in cataractogenesis in some tropical countries Exp Eye Res 31 1980 567 571
92. H.L. Kern, R.W. Bellhorn, and C.M. Peterson Sodium cyanate-induced ocular lesions in the beagle J Pharmacol Exp Ther 200 1977 10 16
93. U.P. Steinbrecher, M. Fisher, J.L. Witztum, and L.K. Curtiss Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine J Lipid Res 25 1984 1109 1116
94. P. Mydel, Z. Wang, and M. Brisslert Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis J Immunol 184 2010 6882 6890
95. J. Shi, R. Knevel, and P. Suwannalai Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage Proc Natl Acad Sci U S A 108 2011 17372 17377
96. -/- mice and bind plasma autoantibodies in humans under enhanced carbamylation Antioxid Redox Signal 19 2013 1047 1062
97. J. Shi, P.A. van Veelen, and M. Mahler Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies Autoimmun Rev 13 2014 225 230
98. P.C. Muller, J. Anink, and J. Shi Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients Ann Rheum Dis 72 2013 2053 2055
99. M. Shaykh, A.A. Pegoraro, and W. Mo Carbamylated proteins activate glomerular mesangial cells and stimulate collagen deposition J Lab Clin Med 133 1999 302 308
100. G. Farias, C. Gonzalez-Billault, and R.B. Maccioni Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau Mol Cell Biochem 168 1997 59 66
101. H.E. Roxborough, C.A. Millar, J. McEneny, and I.S. Young Carbamylation inhibits the ferroxidase activity of caeruloplasmin Biochem Biophys Res Commun 214 1995 1073 1078
102. S. Kimani, V. Moterroso, and M. Lasarev Carbamoylation correlates of cyanate neuropathy and cyanide poisoning: relevance to the biomarkers of cassava cyanogenesis and motor system toxicity Springerplus 2 2013 647
103. S. Kimani, K. Sinei, F. Bukachi, D. Tshala-Katumbay, and C. Maitai Memory deficits associated with sublethal cyanide poisoning relative to cyanate toxicity in rodents Metab Brain Dis 29 2014 105 112
104. R.M. Kassa, N.L. Kasensa, and V.H. Monterroso On the biomarkers and mechanisms of konzo, a distinct upper motor neuron disease associated with food (cassava) cyanogenic exposure Food Chem Toxicol 49 2010 571 578
105. J. Tor-Agbidye, V.S. Palmer, and M.R. Lasarev Bioactivation of cyanide to cyanate in sulfur amino acid deficiency: relevance to neurological disease in humans subsisting on cassava Toxicol Sci 50 1999 228 235
106. R. Fluckiger, W. Harmon, W. Meier, S. Loo, and K.H. Gabbay Hemoglobin carbamylation in uremia N Engl J Med 304 1981 823 827
107. J.T. Kwan, E.C. Carr, J.L. Barron, and M.R. Bending Carbamylated haemoglobin in normal, diabetic and uraemic patients Ann Clin Biochem 29 pt 2 1992 206 209
108. J.T. Kwan, E.C. Carr, J.L. Barron, and M.R. Bending Carbamylated haemoglobin - a retrospective index of time-averaged urea concentration Nephrol Dial Transplant 8 1993 565 567
109. J.T. Kwan, E.C. Carr, and A.D. Neal Carbamylated haemoglobin, urea kinetic modelling and adequacy of dialysis in haemodialysis patients Nephrol Dial Transplant 6 1991 38 43
110. N. Tarif, M. Shaykh, J. Stim, J.A. Arruda, and G. Dunea Carbamylated hemoglobin in hemodialysis patients Am J Kidney Dis 30 1997 361 365
111. A. Davenport, S. Jones, S. Goel, J.P. Astley, and T.G. Feest Carbamylated hemoglobin: a potential marker for the adequacy of hemodialysis therapy in end-stage kidney failure Kidney Int 50 1996 1344 1351
112. Y. Hasuike, T. Nakanishi, and K. Maeda Carbamylated hemoglobin as a therapeutic marker in hemodialysis Nephron 91 2002 228 234
113. 1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age Diabetes Care 21 1998 1732 1735
114. 1c levels in patients with chronic kidney failure on hemodialysis Intern Med 37 1998 826 830
115. 1c levels in non-diabetic patients with end-stage kidney disease (ESRD) receiving hemodialysis J Endocrinol Invest 27 2004 733 735
116. 1c in end-stage kidney disease Diabetes Care 35 2012 1621 1624
117. J. Stim, M. Shaykh, and F. Anwar Factors determining hemoglobin carbamylation in kidney failure Kidney Int 48 1995 1605 1610
118. J.T. Kwan, E.C. Carr, M.R. Bending, and J.L. Barron Determination of carbamylated hemoglobin by high-performance liquid chromatography Clin Chem 36 1990 607 610
119. A. Wynckel, C. Randoux, and H. Millart Kinetics of carbamylated haemoglobin in acute kidney failure Nephrol Dial Transplant 15 2000 1183 1188
120. A. Davenport, S.R. Jones, S. Goel, J.P. Astley, and M. Hartog Differentiation of acute from chronic kidney impairment by detection of carbamylated haemoglobin Lancet 341 1993 1614 1617
121. J.S. Han, Y.S. Kim, and H.J. Chin Temporal changes and reversibility of carbamylated hemoglobin in kidney failure Am J Kidney Dis 30 1997 36 40
122. W.H. Tang, K. Shrestha, and Z. Wang Protein carbamylation in chronic systolic heart failure: relationship with kidney impairment and adverse long-term outcomes J Card Fail 19 2013 219 224
123. D.S. Raj, P. Zager, and V.O. Shah Protein turnover and amino acid transport kinetics in end-stage kidney disease Am J Physiol Endocrinol Metab 286 2004 E136 E143
124. J. Tattersall Do we need another Kt/V? Nephrol Dial Transplant 28 2013 1963 1966
125. W.F. Owen Jr., K.B. Meyer, G. Schmidt, and H. Alfred Methodological limitations of the ESRD Core Indicators Project: an ESRD network's experience with implementing an ESRD quality survey. Medical Review Board of the ESRD Network of New England Am J Kidney Dis 30 1997 349 355
126. M. Holzer, K. Zangger, and D. El-Gamal Myeloperoxidase-derived chlorinating species induce protein carbamylation through decomposition of thiocyanate and urea: novel pathways generating dysfunctional high-density lipoprotein Antioxid Redox Signal 17 2012 1043 1052
127. A.R. Zil, and M.A. Rahman Serum thiocyanate levels in smokers, passive smokers and never smokers J Pak Med Assoc 56 2006 323 326
128. J. Carracedo, A. Merino, and C. Briceno Carbamylated low-density lipoprotein induces oxidative stress and accelerated senescence in human endothelial progenitor cells FASEB J 25 2011 1314 1322